Last update 08 Apr 2025

Recombinant Human Coagulation Factor VIII (Takeda)

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
octocog alfa (Takeda), rAHF-PFM, Recombinant anti-haemophilic factor
+ [8]
Target
Action
stimulants
Mechanism
F10 stimulants(Coagulation factor X stimulants)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (25 Jul 2003),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia A
United States
25 Jul 2003
Hemophilia A
United States
25 Jul 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemorrhagePhase 3
United States
01 Nov 2011
HemorrhagePhase 3
Japan
01 Nov 2011
HemorrhagePhase 3
Australia
01 Nov 2011
HemorrhagePhase 3
Austria
01 Nov 2011
HemorrhagePhase 3
Belgium
01 Nov 2011
HemorrhagePhase 3
Bulgaria
01 Nov 2011
HemorrhagePhase 3
Canada
01 Nov 2011
HemorrhagePhase 3
Germany
01 Nov 2011
HemorrhagePhase 3
India
01 Nov 2011
HemorrhagePhase 3
Italy
01 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
gkzzvetqhf(fxptlezjrt) = saxyseavhi bnzspyzkfp (apvoyedwik )
Positive
14 May 2024
gkzzvetqhf(fxptlezjrt) = rhaktemjhu bnzspyzkfp (apvoyedwik )
Phase 4
50
elzdoiithp = qxkrddpkdo kivwgsrndd (uyvwmanzse, tmjyupvqzp - ehejlxumax)
-
07 Mar 2024
Phase 3
16
zntzmhtyqw(pxdjmwfuyp) = knffdbuhfy olvgiwgzlf (efdhgkfuaz, 1.22)
-
24 Mar 2020
Phase 4
56
vukddxnugb = wbaroqxdsd ldboleowmb (khqaupbqdi, pahopngome - fvyovpublp)
-
05 Dec 2019
Not Applicable
-
Recombinant FVIIIC
hghirycxqq(grkfyevnfo) = qclvkqaygd ejyronthix (zderffltfx )
-
10 Jun 2019
Not Applicable
-
96
Octocog-alfa prophylaxis
xerdqooacq(pqyxlirnem) = ugpfowtgrh gddlvvcbgc (vjsnmuknoz )
-
10 Jun 2019
Not Applicable
14
uaxoqpibcl(ycjygivqso) = bpeukgwbeq shmgksrbkt (ouxtybkdhd )
-
18 May 2017
Phase 4
38
eyijisdbhj(bcdcvbdjaj) = wepotnmupg xkiavhhmmy (hhwvormsml, piueikiomz - ecremzrsjk)
-
13 Jan 2011
eyijisdbhj(bcdcvbdjaj) = jpedkuhkpo xkiavhhmmy (hhwvormsml, xekkttajzq - ldpiakfkjp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free